Arturo Falaschi Conference Series

Preliminary Programme

Stazione Marittima Congress Centre - Sala Saturnia

 

Tuesday 21st November

12.00-14.00

REGISTRATION
1st Floor Foyer, Stazione Marittima Congress Centre

Refreshments

14.30-15.00

Welcome address

Mauro Giacca (Director ICGEB)

15.00

Breaking news in Frontotemporal Dementia
Chairmen: Markus Otto (Ulm, Germany) and Emanuele Buratti (Trieste, Italy)

15.00-15.30

Risk and Modifying factors in Fronto Temporal Dementia (RiMod-FTD)

Peter Heutink (Tubingen, Germany)

15.30-16.00

Molecular neuropathology of FTD:
recent developments

Ian Mackenzie (Vancouver, Canada)

16.00-16.30

Clinical aspects of Primary Progressive Aphasia

Thomas Bak (Edinburgh, UK)

16.30-17.00

Coffee break

 

17.00-17.30

Neuroimaging in Frontotemporal Dementia

James Rowe (Cambridge, UK)

17.30-17.45

The incidence of FTLD: preliminary results from SLAP_Dem , the registry in Puglia, Italy

Giancarlo Logroscino (Bari, Italy)

17.45-18.00

Antisense long non-coding RNA represses MAPT translation through an embedded MIR repeat

Roberto Simone (London, UK)

18.00-18.15

Frontotemporal Lobar Degenerations, Proteinopathies or RNAopathies?

Vincent Anquetil (Paris, France)

18.15-18-30

Exome sequencing in atypical FTD with peri-rolandic atrophy suggests a role for matrix metalloproteinases in FTD

Julie van der Zee (Antwerp, Belgium)

19.00-21.00

Happy hour

 

Wednesday 22nd November

9.00

Breaking news in Frontotemporal Dementia and Frontotemporal Dementia-Motor Neuron Disease
Chairmen: Alessandro Padovani (Brescia, Italy) and Patrizia Longone (Rome, Italy)

9.00-9.30

C9orf72 expression in health and disease

Manuela Neumann (Tuebingen, Germany)

9.30-10.00

C9FTD/ALS - models, markers and more

Leonardo Petrucelli (Mayo Clinic, USA)

10.00-10.30

Frontotemporal syndromes of ALS.  Clinicial and molecular insights

Michael Strong (London Ontario, Canada)

10.30-11.00

Coffee break

 

11.00

Breaking news in early onset Alzheimer Disease and Cerebral Amyloid Angiopathy
Chairmen: Barbara Borroni (Brescia, Italy) and Paolo Manganotti (Trieste, Italy)

11.00-11.30

Synaptic dysfunction in Alzheimer Disease

Elena Marcello (Milan, Italy)

11.30-12.00

New criteria of Alzheimer Disease: the atypical cases

Bruno Dubois (Paris, France)

12.00-12.30

New insights into Cerebral Amyloid Angiopathy

Fabrizio Tagliavini (Milan, Italy)

12.30-13.00

The emerging picture of early Alzheimer’s Disease

Paola Marcon (Biogen, Milan, Italy)

13.00-14.00

Lunch

 

14.00

Breaking news in rare forms of dementia
Chairmen: Sandro Sorbi (Firenze, Italy) and Antonella Alberici (Brescia, Italy)

14.00-14.30

Advances in human prion disorders diagnosis

Gianluigi Zanusso (Verona, Italy)

14.30-15.00

Niemann-Pick C: when diseases don't respect borders

Amalia Bruni (Lamezia Terme, Italy)

15.00-15.30

Co-occurrence of autoimmune disease within atypical dementias

Zachary Miller (San Francisco, USA)

15.30-15.45

Hexanucleotide repeat RNA foci from C9ORF72 expansion mutation form paraspeckle-like bodies

Boris Rogelj (Ljubljana, Slovenia)

15.45-16.00

The FTD-ALS spectrum

Vincenzo Silani (Milan, Italy)

16.00-16.15

Anti-AMPA GluA3 antibodies in Frontotemporal dementia: a new molecular target

Fabrizio Gardoni (Milan, Italy)

16.15-16.30

Functional and structural brain networks in posterior cortical atrophy: a two-centre study

Elisa Canu (Milan, Italy)

16.30-18.00

Poster session with wine and cheese

Thursday 23rd November

9.00

Dementia with Lewy Bodies and Parkinson Disease Dementia
Chairmen: Paolo Calabresi (Perugia, Italy) and Annachiara Cagnin (Padova, Italy)

9.00-9.30

Twenty years of alpha-synucleopathies

Maria Grazia Spillantini (Cambridge, UK)

9.30-10.00

Progress in diagnosis of Dementia with Lewy Bodies

Zuzana Walker (UCL, London)

10.00-10.30

EEG in Dementia with Lewy Body

Marco Onofrj (Chieti, Italy)

10.30-11.00

Coffee break

 

11.00-11.30

The contribution of non-invasive brain stimulation in the diagnosis and management of dementia

Federico Ranieri (Rome, Italy)

11.30-11.45

Considerations on PTRHD1 and possibly ADORA1 mutations as contributors to Parkinsonism with intellectual disability

Elahe Elahi (Tehran, Iran)

11.45-12.00

The clinical profile associated to Amyloid-beta 42 and Tau cerebrospinal fluid levels in non-demented PD patients

Inga Liepelt-Scarfone (Tübingen, Germany)

12.00-12.10

Abstract awards

 

12.10-12.30

Closing remarks

Emanuele Buratti (Trieste, Italy) and Alessandro Padovani (Brescia, Italy)

 

 

 

 

Meetings&Courses Unit 11/10/2017